NCT06438952 Efficacy and Duration of Pain Relief in Transforaminal and Lumbar Sympathetic Blocks
| NCT ID | NCT06438952 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Bezmialem Vakif University |
| Condition | Low Back Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2024-06 |
| Primary Completion | 2024-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2024-06 with a primary completion date of 2024-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Low back pain is a symptom that is frequently seen in the general population and reduces the quality of life of patients. Conventional medical treatment for patients with low back pain includes oral medication, lifestyle modification, education, exercises, lumbar traction and manual manipulation, heat application, and other interventional procedures. Epidural injections, one of the interventional procedures, are one of the common treatment methods for low back pain, especially caused by disc prolapse. Steroids are commonly used to reduce inflammation in the epidural space. Epidural steroid injection can be given to the lumbar epidural space via transforaminal, interlaminar and caudal routes, and the effectiveness rate of each is different. These interventional methods used to treat low back pain can be applied in combination. The main purpose of this study is to observe how adding lumbar sympathetic blockade will affect the patient's pain in the postoperative period in patients to whom we applied caudal epidural and transforaminal steroid injection.
Eligibility Criteria
Inclusion Criteria: * ASA I-II-III * Patients who underwent facet joint injection and transforaminal injection due to lumbar disc herniation Exclusion Criteria: * Patients with known allergies to the drugs to be used in treatment * Infection near the puncture site * Known coagulation disorders * Patients with internal fixation or severe anatomical variation such as scoliosis and tumor * History of sympathetic chemical or thermal neurolysis * Alcohol and drug use * Disorder of consciousness * Liver failure, renal failure, advanced cardiac failure * Uncontrolled diabetes mellitus * Morbid obesity (body mass index (BMI) \> 35 kg m-2) * Female patients during pregnancy and breastfeeding * Not approving the informed consent form
Contact & Investigator
Zübeyde Özdemir
STUDY CHAIR
ethics committee chairman
Frequently Asked Questions
Who can join the NCT06438952 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Low Back Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06438952 currently recruiting?
Yes, NCT06438952 is actively recruiting participants. Contact the research team at etikkurul@bezmialem.edu.tr for enrollment information.
Where is the NCT06438952 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye), Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06438952 clinical trial?
NCT06438952 is sponsored by Bezmialem Vakif University. The principal investigator is Zübeyde Özdemir at ethics committee chairman. The trial plans to enroll 20 participants.